בטמיגה 50 מג ישראל - עברית - Ministry of Health

בטמיגה 50 מג

astellas pharma international b.v., israel - mirabegron - טבליות בשחרור ממושך - mirabegron 50 mg - mirabegron

בטמיגה 50 מג ישראל - עברית - Ministry of Health

בטמיגה 50 מג

astellas pharma international b.v., israel - mirabegron - טבליות בשחרור ממושך - mirabegron 50 mg - mirabegron

מגלוטקט CP ישראל - עברית - Ministry of Health

מגלוטקט cp

kamada ltd, israel - cytomegalovirus antibody; human plasma protein; immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 96 %; human plasma protein 50 mg/ml; cytomegalovirus antibody 100 u/ml - cytomegalovirus immunoglobulin

רופינירול טבע   0.25 מג ישראל - עברית - Ministry of Health

רופינירול טבע 0.25 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 0.25 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע  2 מג ישראל - עברית - Ministry of Health

רופינירול טבע 2 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רפמיון 1 מג טבליות ישראל - עברית - Ministry of Health

רפמיון 1 מג טבליות

pfizer pharmaceuticals israel ltd - sirolimus - טבליות מצופות - sirolimus 1 mg - sirolimus

ולפורל קפסולות ישראל - עברית - Ministry of Health

ולפורל קפסולות

teva pharmaceutical industries ltd, israel - valproic acid - קפסולות - valproic acid 200 mg - valproic acid - valproic acid - sole or adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. may also be used adjunctively in patients with multiple seizure types which include absence seizures.

ולפורל קפסולות ישראל - עברית - Ministry of Health

ולפורל קפסולות

teva pharmaceutical industries ltd, israel - valproic acid - קפסולות - valproic acid 200 mg - valproic acid - valproic acid - sole or adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. may also be used adjunctively in patients with multiple seizure types which include absence seizures.

מונטלוקאסט - תרימה 4 מג ישראל - עברית - Ministry of Health

מונטלוקאסט - תרימה 4 מג

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 4 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

מונטלוקאסט - תרימה 5 מג ישראל - עברית - Ministry of Health

מונטלוקאסט - תרימה 5 מג

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 5 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.